BioSpace News Archive

Disc Medicine, Inc. today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to DISC-0974 for the treatment of patients with non-dialysis dependent chronic kidney disease (NDD-CKD) and anemia.

NRx Pharmaceuticals, Inc. today announced that Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx Pharmaceuticals, will present a corporate overview at the BIO CEO & Investor Conference, which is scheduled to take place February 26-27, 2024, at the Marriott Marquis in New York City.

Today, Thermo Fisher Scientific announced the latest recipients of the Oncomine Clinical Research Grant, recognizing research from the Melanoma Institute Australia, the University of Turin in Italy and Atrium Health Wake Forest Baptist Medical Center.

Vicarious Surgical Inc. today announced the Company will participate in the TD Cowen 44th Annual Healthcare Conference.

Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full-year 2023 financial results will be released on Tuesday, March 5, 2024, after the close of the stock market.

Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 from independent clinical experience by physicians at the University Hospital Augsburg, Germany.

Fractyl Health, Inc. today announced the appointment of Samuel Conaway to its Board of Directors.

GT Medical Technologies, Inc. today announced that Per Langoe, a proven industry leader with in-depth radiation oncology experience has joined the company as CEO.

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) today announced topline results from its clinical study comparing repeat doses of neffy (epinephrine nasal spray) to repeat doses of epinephrine intramuscular (IM) injection, as requested by the FDA with and without nasal allergen challenge (NAC) conditions.

Gemini BioProducts Holding, Inc. announced the appointment of Mike Guerra to its Board of Directors.